Skip to main content

Closed

AMGN: Amgen Inc. Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+18.6% / yr

Operating margin31.6%

ROIC13.9%

Financially safe

Strong

Debt / equity6.24×

Interest coverage4.4×

Current ratio1.26×

Valuation

Unrated

P/E ratio26.6×

Dividend yield2.5%

Amgen Inc.

AMGNNASDAQ Global Select·USD·Closed

Amgen Inc.

AMGNNASDAQ·USD·Closed

$385.16

−0.64%

$385.16

−$2.48 (0.64%)

52W Range

90thpctl

Volume

0.71×avg

Mkt Cap

207.87BUSD

P/E

26.6TTM

Div Yield

2.54%ann

52W Range

90thpctl

Volume

0.71×avg

Market Cap

207.87BUSD

P/E Ratio

26.6TTM

Div Yield

2.54%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings